Geode Capital Management, LLC 89bio, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,914,614 shares of ETNB stock, worth $19.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,914,614

Previous 1,740,867 9.98%

Holding current value

$19.1 Million

Previous $20.3 Million 24.32%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$7.31 - $10.9 $1.27 Million - $1.89 Million	173,747 Added 9.98%	1,914,614 $15.3 Million
Q1 2024 May 13, 2024	BUY	$8.13 - $13.77 $2.95 Million - $5 Million	363,157 Added 26.36%	1,740,867 $20.3 Million
Q4 2023 Feb 13, 2024	BUY	$6.66 - $16.03 $557,588 - $1.34 Million	83,722 Added 6.47%	1,377,710 $15.4 Million
Q3 2023 Nov 13, 2023	BUY	$15.06 - $19.41 $1.76 Million - $2.27 Million	116,999 Added 9.94%	1,293,988 $20 Million
Q2 2023 Aug 11, 2023	BUY	$14.15 - $22.03 $9.52 Million - $14.8 Million	673,044 Added 133.56%	1,176,989 $22.3 Million
Q1 2023 May 15, 2023	BUY	$10.48 - $16.94 $1.68 Million - $2.71 Million	160,089 Added 46.56%	503,945 $7.68 Million
Q4 2022 Feb 13, 2023	BUY	$5.52 - $12.73 $563,856 - $1.3 Million	102,148 Added 42.26%	343,856 $4.38 Million
Q3 2022 Nov 14, 2022	BUY	$3.02 - $7.0 $455,002 - $1.05 Million	150,663 Added 165.48%	241,708 $1.4 Million
Q2 2022 Aug 12, 2022	SELL	$2.09 - $4.02 $160,714 - $309,125	-76,897 Reduced 45.79%	91,045 $293,000
Q1 2022 May 13, 2022	BUY	$3.45 - $14.99 $10,146 - $44,085	2,941 Added 1.78%	167,942 $633,000
Q4 2021 Feb 11, 2022	SELL	$11.15 - $19.66 $148,562 - $261,949	-13,324 Reduced 7.47%	165,001 $2.16 Million
Q3 2021 Nov 12, 2021	BUY	$14.91 - $21.31 $313,959 - $448,724	21,057 Added 13.39%	178,325 $3.49 Million
Q2 2021 Aug 13, 2021	BUY	$17.42 - $28.0 $247,433 - $397,712	14,204 Added 9.93%	157,268 $2.94 Million
Q1 2021 May 12, 2021	BUY	$20.22 - $26.73 $378,902 - $500,893	18,739 Added 15.07%	143,064 $3.39 Million
Q4 2020 Feb 12, 2021	BUY	$23.16 - $28.08 $607,579 - $736,650	26,234 Added 26.74%	124,325 $3.03 Million
Q3 2020 Nov 13, 2020	BUY	$24.34 - $38.82 $660,514 - $1.05 Million	27,137 Added 38.25%	98,091 $2.52 Million
Q2 2020 Aug 13, 2020	BUY	$19.93 - $31.2 $38,903 - $60,902	1,952 Added 2.83%	70,954 $1.41 Million
Q1 2020 May 14, 2020	BUY	$16.4 - $41.77 $212,691 - $541,715	12,969 Added 23.15%	69,002 $1.74 Million
Q4 2019 Feb 13, 2020	BUY	$19.75 - $33.44 $1.11 Million - $1.87 Million	56,033 New	56,033 $1.47 Million

Others Institutions Holding ETNB

# of Institutions

157

Shares Held

107M

Call Options Held

65K

Put Options Held

1.2M

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $463M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC 89bio, Inc. Transaction History